Notice2023-02972
Notice of Closed Meeting
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
February 13, 2023
Issuing agencies
Health and Human Services DepartmentCenters for Disease Control and Prevention
Full Text
<html>
<head>
<title>Federal Register, Volume 88 Issue 29 (Monday, February 13, 2023)</title>
</head>
<body><pre>
[Federal Register Volume 88, Number 29 (Monday, February 13, 2023)]
[Notices]
[Page 9289]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2023-02972]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Notice of Closed Meeting
Pursuant to 5 U.S.C. 1009(d), notice is hereby given of the
following meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended, and the Determination of the Director, Strategic
Business Initiatives Unit, Office of the Chief Operating Officer, CDC,
pursuant to Public Law 117-286. The grant applications and the
discussions could disclose confidential trade secrets or commercial
property such as patentable material, and personal information
concerning individuals associated with the grant applications, the
disclosure of which would constitute a clearly unwarranted invasion of
personal privacy.
Name of Committee: Disease, Disability, and Injury Prevention and
Control Special Emphasis Panel (SEP)--PS23-004, Long-Acting Injectables
for the Treatment of HIV in Non-Clinic Community-Based Settings and
PS23-006, Identifying and Addressing Historical and Structural Drivers
of Medical Mistrust among Hispanic/Latino Gay, Bisexual and Other Men
Who Have Sex with Men (HLMSM) for HIV Prevention.
Date: April 26-27, 2023.
Time: 10 a.m.-5 p.m. (EDT).
Place: Teleconference, Centers for Disease Control and Prevention,
Room 1077, 8 Corporate Blvd., Atlanta, GA 30329.
Agenda: To review and evaluate grant applications.
For Further Information Contact: Gregory Anderson, M.S., M.P.H.,
Scientific Review Officer, National Center for HIV, Viral Hepatitis,
STD, and TB Prevention, CDC, 1600 Clifton Road NE, Mailstop US8-1,
Atlanta, Georgia 30329, Telephone: (404) 718-8833, Email:
<a href="/cdn-cgi/l/email-protection#da9d9bb4bebfa8a9b5b49ab9beb9f4bdb5ac"><span class="__cf_email__" data-cfemail="a7e0e6c9c3c2d5d4c8c9e7c4c3c489c0c8d1">[email protected]</span></a>.
The Director, Strategic Business Initiatives Unit, Office of the
Chief Operating Officer, Centers for Disease Control and Prevention,
has been delegated the authority to sign Federal Register notices
pertaining to announcements of meetings and other committee management
activities, for both the Centers for Disease Control and Prevention and
the Agency for Toxic Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2023-02972 Filed 2-10-23; 8:45 am]
BILLING CODE 4163-18-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on February 13, 2023.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.